Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Radius Health, Inc.Listing unverified | Buy | $4M | conv 36First in 12mo | SEC | |
NANOSPHERE INCListing unverified | Sell | $63.2K | SEC | ||
NANOSPHERE INCListing unverified | Sell | $1.8M | SEC | ||
Radius Health, Inc.Listing unverified | BuyD (derivative) | $3.3M | ClusterFirst in 12mo | SEC | |
Radius Health, Inc.Listing unverified | BuyD (derivative) | $3.3M | Cluster | SEC | |
DOMINOS PIZZA INCListing on record | Sell | $902.2K | SEC | ||
DOMINOS PIZZA INCListing on record | Sell | $2.1M | SEC | ||
DOMINOS PIZZA INCListing on record | Sell | $3.6M | SEC | ||
NANOSPHERE INCListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
NANOSPHERE INCListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
NANOSPHERE INCListing unverified | Buy | $12.5M | conv 50Cluster | SEC | |
NANOSPHERE INCListing unverified | OtherD (derivative) | $6.5M | SEC | ||
NANOSPHERE INCListing unverified | OtherD (derivative) | $6.5M | SEC | ||
NANOSPHERE INCListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Targanta Therapeutics Corp.Listing unverified | Buy | $5.8M | conv 49Cluster | SEC | |
Targanta Therapeutics Corp.Listing unverified | OtherD (derivative) | $866.9K | SEC | ||
Targanta Therapeutics Corp.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Targanta Therapeutics Corp.Listing unverified | OtherD (derivative) | $1.1M | SEC | ||
Targanta Therapeutics Corp.Listing unverified | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
MAP Pharmaceuticals, Inc.Listing unverified | Other | $1.7M | SEC | ||
MAP Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | $16.3M | SEC | ||
MAP Pharmaceuticals, Inc.Listing unverified | Buy | $7.2M | conv 61ClusterFirst in 12mo | SEC | |
MAP Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | $16.9M | SEC | ||
MAP Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC |